ISTAART Voices Part 2 (CME, Physician Assistant CME, CNE, Pharmacy CEUs, ABIM MOC Part 2)

Activity Available: February 27, 2025 – February 27, 2027

Education Activity Description:

Listen to ISTAART Voices Part 2, a new offering from the Alzheimer’s Association the International Society to Advance Alzheimer Research and Treatment (ISTAART). ISTAART Voices Part 2 navigates the intricate world of dementia research and treatment in conversation with the researchers who are shaping the field.

Jointly provided by Postgraduate Institute for Medicine and Alzheimer’s Association

Estimated time to complete activity: Approximately 30 minutes per episode (0.5 Credits)

Learning Objectives:

Episode 8: Exploring the Finer Details of Cognitive Decline in Parkinson's Disease

Identify clinical profiles susceptible to cognitive decline in Parkinson’s Disease.

Episode 9: Decoding Alzheimer's: Using Algorithms To Predict Cognitive Decline

Describe the best performing model to distinguish between the Positive-Ager and Cognitive Decliner groups.

Episode 10: Alzheimer's and the LGBTQIA+ Community: Uncovering Unique Challenges

Describe the actionable recommendations for researchers, institutions, and policymakers seeking to bridge the gap in LGBTQIA+ representation in ADRD research.

Episode 11: The Intricate Interplay of Alzheimer's and Lewy Body Pathologies

Explain the utility of α-syn SAA for the in vivo molecular assessment of comorbid LB-pathology in the context of dementia.

Episode 12: Protein Signatures, Blood Vessels and Alzheimer’s Disease

Identify cerebrovascular deficits in AD and potential biomarkers associated with CAA and vascular dysfunction in neurodegenerative diseases.

Episode 13: Hearing, Conversation, and Cognitive Decline: Tracing Complex Connections

Describe the importance of addressing self-reported hearing loss and isolation with lack of conversation for prevention of dementia in older adults.

Episode 14: Alzheimer’s Treatments and Other Drugs: Comparing Biologics

Compare emerging Alzheimer’s treatments to biologics used in cancer and other diseases. 

Episode 15: Exploring Divorce, Widowhood, Emotional Stress, and Dementia Risk

Describe how marital dissolution may contribute to increased amyloid pathology and memory decline. 

Faculty Disclosure Information

Episode 8: Dana Pourzinal, PhD Postdoctoral Research Fellow, UQ Centre for Clinical Research, Faculty of Medicine has nothing to disclose.

Episode 9: Jason D. Flatt, PhD, MPH, Associate Professor, School of Public Health, Department of Social & Behavioral Health, University of Nevada, Las Vegas has nothing to disclose.

Episode 10: 
Mohammad Fili, PhD Visiting Assistant Professor, Industrial Engineering and Management, Oklahoma State University has nothing to disclose. 
Auriel A. Willette, PhD Associate Professor,Institute for Health, Health Care Policy, and Aging Research, Department of Neurology, Robert Wood Johnson Medical School, Rutgers University has nothing to disclose.  

Episode 11:
Duygu Tosun, PhD, Director, Medical Imaging Informatics + Artificial Intelligence Professor, UCSF Department of Radiology and Biomedical Imaging has disclosed a Consultant/Advisory Board relationship with: Roche, Veravas, Alzheon. 

Episode 12:
Aleksandra M. Wojtas, PhD, Postdoctoral Fellow, Department of Biochemistry, Emory University School of Medicine has nothing to disclose.
Nicholas T. Seyfried,  PhD, Professor Department of Biochemistry, Director Emory Integrated Proteomics Core, Emory University School of Medicine has disclosed the following relationships - Employee/Owner: Emtherapro, Arc Protoemics, Stitch Rx and Non-Mutual funds Stock Ownership/Stock options: Emtherapro, Stitch.

Episode 13:
Kouki Tomida, PhD, Department of Preventive Gerontology, Center for Gerontology and Social Science, National Center for Geriatrics and Gerontology has nothing to disclose.
Joshua Stevenson-Hoare, PhD, Clinical Epidemiology and Aging Research,Postdoctoral Researcher, DKFZ-Heidelberg has nothing to disclose.

Episode 14:
Gregory Jicha, MD, PhD, Director, UK Telemedicine Cognitive Clinic, Professor, Department of Neurology, University of Kentucky College of Medicine has the following disclosed relationships - Contract Research for: AbbVie, Alnylam, Cassava, Cognition Therapeutics, Eisai, Lilly, Neurovision, Novo Nordisk
Peter Nelson, MD, PhD, Director of Neuropathology, Sanders-Brown Center of Aging Professor, Pathology and Laboratory Medicine, University of Kentucky College of Medicine has nothing to disclose.

Episode 15:
Avinash Chandra, PhD, Postdoctoral Research Assistant, Wolfson Institute of Population Health, Queen Mary University of London has nothing to disclose.

 

Accreditation Information

Disclosure of Unlabeled Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Target Audience: This activity is intended to meet the educational needs of primary care clinicians including internists, family physicians, radiologists, neurologists, nurse practitioners, nurses, physician assistants, pharmacists, and psychologists who are seeking additional education in the assessment, diagnosis and ongoing health care of patients with cognitive impairment and dementia.

Statement of Purpose: A practice gap is the difference between what healthcare professionals should or could be doing and what they are currently doing. Using current evidence based research to bridge the gap between patient care and care recommendation, the Alzheimer's Association is ensuring healthcare professionals are not only aware of current practice but are utilizing them in patient care settings. 

Joint Accreditation

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Alzheimer's Association. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designations:

Physician Continuing Medical Education; The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™ per episode. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Physician Assistant Education: 

Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 Category 1 CME credits per episode. Approval is valid until 1/8/2026. PAs should only claim credit commensurate with the extent of their participation.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Continuing Nursing Education: The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours per episode. This activity is being presented without bias and without commercial support.

Continuing Pharmacy Education: Postgraduate Institute for Medicine designates this continuing education activity for 0.5 contact hour(s) (0.05 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number -

Type of Activity: Application

For additional questions please contact clinical education staff at clinicaledu@alz.org